✦ LIBER ✦

The cytocidal action of metronidazole in combination with other antineoplastic agents

✍ Scribed by Kelly, J.P.; Hannam, T.W.; Giles, G.R.

Book ID: 123584247
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 704 KB
Volume: 6
Category: Article
ISSN: 0305-7372
DOI: 10.1016/S0305-7372(79)80013-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The mode of action of metronidazole in T

The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms

✍ Robert M.J. Ings; James A. McFadzean; Walter E. Ormerod 📂 Article 📅 1974 🏛 Elsevier Science 🌐 English ⚖ 558 KB

Activity of gatifloxacin and ciprofloxac

Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents

✍ E. Gradelski; B. Kolek; D.P. Bonner; L. Valera; B. Minassian; J. Fung-Tomc 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Brostallicin potentates the antitumor ac

Brostallicin potentates the antitumor activity of other cytotoxic antineoplastic agents in experimental tumor models

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Filament Formation in E. coli Induced by

Filament Formation in E. coli Induced by Azaserine and Other Antineoplastic Agents

✍ Maxwell, R. E.; Nickel, V. S. 📂 Article 📅 1954 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 294 KB

Evaluation of toxicity and efficacy of a

Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR

✍ Mohamed Salah-Eldin; Gholam A. Peyman; Mohamed El-Aswad; Bothaina Bandok; Mostaf 📂 Article 📅 1994 🏛 Springer Netherlands 🌐 English ⚖ 976 KB

Effects of CPT-11 in combination with ot

Effects of CPT-11 in combination with other anti-cancer agents in culture

✍ Yasuhiko Kano; Kenichi Suzuki; Miyuki Akutsu; Keiichi Suda; Yoshiharu Indue; Min 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 746 KB

CPT-I I , 7-ethyl-I0-[4-( I -piperidino)-I -piperidino]carbonyloxy camptothecin, is a newly developed water-soluble camptothecin derivative now undergoing phase4 evaluation. In an attempt to establish whether the combination of CPT-I I with other standard anti-cancer agents would be of any benefit,